FDA NDC Directory · JSON-LD · Markdown

Regadenoson

NDC 68083-175 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Labeler / ManufacturerGland Pharma Limited
Marketing categoryAbbreviated NDA (generic) · App ANDA207320
Dosage form / routeINJECTION, SOLUTION · INTRAVENOUS
Active ingredientsREGADENOSON (.08 mg/mL)
Marketing started20220712
Package count1

External sources

Source: openFDA. Public-domain (CC0).